nodes	percent_of_prediction	percent_of_DWPC	metapath
Sulfasalazine—PLA2G1B—coronary artery disease	0.255	0.699	CbGaD
Sulfasalazine—PPARG—coronary artery disease	0.0774	0.212	CbGaD
Sulfasalazine—SLC7A11—Rosuvastatin—coronary artery disease	0.0632	0.13	CbGbCtD
Sulfasalazine—IKBKB—Acetylsalicylic acid—coronary artery disease	0.0616	0.126	CbGbCtD
Sulfasalazine—PPARG—Telmisartan—coronary artery disease	0.0412	0.0846	CbGbCtD
Sulfasalazine—PTGS2—coronary artery disease	0.0327	0.0895	CbGaD
Sulfasalazine—SLCO1B1—Gemfibrozil—coronary artery disease	0.0187	0.0384	CbGbCtD
Sulfasalazine—SLCO1B1—Olmesartan—coronary artery disease	0.0177	0.0364	CbGbCtD
Sulfasalazine—ABCC2—Olmesartan—coronary artery disease	0.0156	0.0319	CbGbCtD
Sulfasalazine—SLCO1B1—Pitavastatin—coronary artery disease	0.0142	0.0291	CbGbCtD
Sulfasalazine—SLCO1B1—Valsartan—coronary artery disease	0.0138	0.0283	CbGbCtD
Sulfasalazine—ABCC2—Pitavastatin—coronary artery disease	0.0124	0.0255	CbGbCtD
Sulfasalazine—ABCC2—Telmisartan—coronary artery disease	0.0124	0.0255	CbGbCtD
Sulfasalazine—ABCG2—Pitavastatin—coronary artery disease	0.0113	0.0231	CbGbCtD
Sulfasalazine—ABCG2—Telmisartan—coronary artery disease	0.0113	0.0231	CbGbCtD
Sulfasalazine—SLCO1B1—Rosuvastatin—coronary artery disease	0.0104	0.0214	CbGbCtD
Sulfasalazine—SLCO1B1—Ezetimibe—coronary artery disease	0.0104	0.0214	CbGbCtD
Sulfasalazine—SLCO1B1—Simvastatin—coronary artery disease	0.00971	0.0199	CbGbCtD
Sulfasalazine—SLCO1B1—Pravastatin—coronary artery disease	0.0095	0.0195	CbGbCtD
Sulfasalazine—SLCO1B1—Lovastatin—coronary artery disease	0.0095	0.0195	CbGbCtD
Sulfasalazine—ABCC2—Ezetimibe—coronary artery disease	0.00918	0.0188	CbGbCtD
Sulfasalazine—PTGS2—Acetylsalicylic acid—coronary artery disease	0.00884	0.0181	CbGbCtD
Sulfasalazine—SLCO1B1—Atorvastatin—coronary artery disease	0.00865	0.0178	CbGbCtD
Sulfasalazine—ABCC2—Simvastatin—coronary artery disease	0.00853	0.0175	CbGbCtD
Sulfasalazine—ABCC2—Lovastatin—coronary artery disease	0.00835	0.0171	CbGbCtD
Sulfasalazine—ABCC2—Pravastatin—coronary artery disease	0.00835	0.0171	CbGbCtD
Sulfasalazine—ABCG2—Rosuvastatin—coronary artery disease	0.0083	0.017	CbGbCtD
Sulfasalazine—ABCG2—Ezetimibe—coronary artery disease	0.0083	0.017	CbGbCtD
Sulfasalazine—SLCO1B1—Losartan—coronary artery disease	0.00791	0.0162	CbGbCtD
Sulfasalazine—ABCC2—Atorvastatin—coronary artery disease	0.0076	0.0156	CbGbCtD
Sulfasalazine—ABCG2—Pravastatin—coronary artery disease	0.00755	0.0155	CbGbCtD
Sulfasalazine—PTGS1—Acetylsalicylic acid—coronary artery disease	0.00746	0.0153	CbGbCtD
Sulfasalazine—CYP3A5—Clopidogrel—coronary artery disease	0.00713	0.0146	CbGbCtD
Sulfasalazine—ABCC2—Furosemide—coronary artery disease	0.0071	0.0146	CbGbCtD
Sulfasalazine—CYP3A5—Eplerenone—coronary artery disease	0.00663	0.0136	CbGbCtD
Sulfasalazine—CYP3A5—Rosuvastatin—coronary artery disease	0.0046	0.00943	CbGbCtD
Sulfasalazine—CYP3A5—Simvastatin—coronary artery disease	0.00427	0.00877	CbGbCtD
Sulfasalazine—CYP3A5—Pravastatin—coronary artery disease	0.00418	0.00858	CbGbCtD
Sulfasalazine—CYP3A5—Lovastatin—coronary artery disease	0.00418	0.00858	CbGbCtD
Sulfasalazine—CYP3A5—Atorvastatin—coronary artery disease	0.00381	0.00781	CbGbCtD
Sulfasalazine—CYP3A5—Losartan—coronary artery disease	0.00348	0.00715	CbGbCtD
Sulfasalazine—ACAT1—cardiac ventricle—coronary artery disease	0.00184	0.072	CbGeAlD
Sulfasalazine—ACAT1—myocardium—coronary artery disease	0.00173	0.0677	CbGeAlD
Sulfasalazine—ACAT1—heart—coronary artery disease	0.00121	0.0473	CbGeAlD
Sulfasalazine—ACAT1—cardiovascular system—coronary artery disease	0.00114	0.0446	CbGeAlD
Sulfasalazine—PPARG—artery—coronary artery disease	0.00103	0.0404	CbGeAlD
Sulfasalazine—ACAT1—cardiac atrium—coronary artery disease	0.00103	0.0404	CbGeAlD
Sulfasalazine—TBXAS1—heart—coronary artery disease	0.00101	0.0395	CbGeAlD
Sulfasalazine—TBXAS1—cardiovascular system—coronary artery disease	0.000952	0.0373	CbGeAlD
Sulfasalazine—CHUK—heart—coronary artery disease	0.000899	0.0352	CbGeAlD
Sulfasalazine—PPARG—endothelium—coronary artery disease	0.000872	0.0342	CbGeAlD
Sulfasalazine—CHUK—cardiovascular system—coronary artery disease	0.000848	0.0332	CbGeAlD
Sulfasalazine—PLA2G1B—heart—coronary artery disease	0.000845	0.0331	CbGeAlD
Sulfasalazine—PLA2G1B—cardiovascular system—coronary artery disease	0.000798	0.0312	CbGeAlD
Sulfasalazine—TBXAS1—blood—coronary artery disease	0.000753	0.0295	CbGeAlD
Sulfasalazine—CHUK—blood—coronary artery disease	0.000671	0.0263	CbGeAlD
Sulfasalazine—PLA2G1B—blood—coronary artery disease	0.000631	0.0247	CbGeAlD
Sulfasalazine—IKBKB—heart—coronary artery disease	0.000611	0.0239	CbGeAlD
Sulfasalazine—IKBKB—cardiovascular system—coronary artery disease	0.000577	0.0226	CbGeAlD
Sulfasalazine—PTGS1—artery—coronary artery disease	0.000552	0.0216	CbGeAlD
Sulfasalazine—PPARG—myocardium—coronary artery disease	0.000545	0.0213	CbGeAlD
Sulfasalazine—PTGS2—artery—coronary artery disease	0.000528	0.0207	CbGeAlD
Sulfasalazine—ALOX5—heart—coronary artery disease	0.000507	0.0198	CbGeAlD
Sulfasalazine—ALOX5—cardiovascular system—coronary artery disease	0.000478	0.0187	CbGeAlD
Sulfasalazine—Balsalazide—PPARG—coronary artery disease	0.00047	0.293	CrCbGaD
Sulfasalazine—PTGS1—endothelium—coronary artery disease	0.000466	0.0183	CbGeAlD
Sulfasalazine—IKBKB—blood—coronary artery disease	0.000456	0.0179	CbGeAlD
Sulfasalazine—PTGS2—endothelium—coronary artery disease	0.000446	0.0175	CbGeAlD
Sulfasalazine—Olsalazine—PPARG—coronary artery disease	0.0004	0.249	CrCbGaD
Sulfasalazine—PPARG—heart—coronary artery disease	0.00038	0.0149	CbGeAlD
Sulfasalazine—ALOX5—blood—coronary artery disease	0.000378	0.0148	CbGeAlD
Sulfasalazine—PPARG—cardiovascular system—coronary artery disease	0.000359	0.0141	CbGeAlD
Sulfasalazine—SLCO1B1—blood—coronary artery disease	0.000329	0.0129	CbGeAlD
Sulfasalazine—PTGS1—myocardium—coronary artery disease	0.000291	0.0114	CbGeAlD
Sulfasalazine—PPARG—blood—coronary artery disease	0.000284	0.0111	CbGeAlD
Sulfasalazine—ABCC2—blood—coronary artery disease	0.000249	0.00977	CbGeAlD
Sulfasalazine—ABCG2—heart—coronary artery disease	0.000244	0.00955	CbGeAlD
Sulfasalazine—Vismodegib—CYP2C19—coronary artery disease	0.000238	0.148	CrCbGaD
Sulfasalazine—PTGS1—heart—coronary artery disease	0.000203	0.00796	CbGeAlD
Sulfasalazine—Balsalazide—PTGS2—coronary artery disease	0.000199	0.124	CrCbGaD
Sulfasalazine—PTGS2—heart—coronary artery disease	0.000194	0.00761	CbGeAlD
Sulfasalazine—PTGS1—cardiovascular system—coronary artery disease	0.000192	0.00751	CbGeAlD
Sulfasalazine—PTGS2—cardiovascular system—coronary artery disease	0.000183	0.00718	CbGeAlD
Sulfasalazine—ABCG2—blood—coronary artery disease	0.000182	0.00713	CbGeAlD
Sulfasalazine—PTGS1—cardiac atrium—coronary artery disease	0.000174	0.00681	CbGeAlD
Sulfasalazine—Olsalazine—PTGS2—coronary artery disease	0.000169	0.105	CrCbGaD
Sulfasalazine—CYP3A5—blood—coronary artery disease	0.000169	0.00661	CbGeAlD
Sulfasalazine—PTGS1—blood—coronary artery disease	0.000152	0.00594	CbGeAlD
Sulfasalazine—PTGS2—blood—coronary artery disease	0.000145	0.00568	CbGeAlD
Sulfasalazine—Vismodegib—ALB—coronary artery disease	0.000132	0.0821	CrCbGaD
Sulfasalazine—SLCO1B1—Metabolism—PPP2CA—coronary artery disease	1.7e-06	1.41e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Disease—SERPINE1—coronary artery disease	1.7e-06	1.41e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Innate Immune System—PIK3CA—coronary artery disease	1.7e-06	1.41e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—PPP2CA—coronary artery disease	1.7e-06	1.41e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—TGFBR2—coronary artery disease	1.7e-06	1.41e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—KITLG—coronary artery disease	1.7e-06	1.41e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—BCL2—coronary artery disease	1.69e-06	1.4e-05	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism—APOB—coronary artery disease	1.69e-06	1.4e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—EDN1—coronary artery disease	1.69e-06	1.4e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—PLCB1—coronary artery disease	1.69e-06	1.4e-05	CbGpPWpGaD
Sulfasalazine—ABCG2—Metabolism—LPL—coronary artery disease	1.68e-06	1.39e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—CCL5—coronary artery disease	1.68e-06	1.39e-05	CbGpPWpGaD
Sulfasalazine—PPARG—Developmental Biology—AKT1—coronary artery disease	1.67e-06	1.39e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—PRKCD—coronary artery disease	1.67e-06	1.38e-05	CbGpPWpGaD
Sulfasalazine—PPARG—Metabolism—POMC—coronary artery disease	1.66e-06	1.38e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—STAT5A—coronary artery disease	1.66e-06	1.38e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—CSF2—coronary artery disease	1.65e-06	1.37e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—FGF1—coronary artery disease	1.65e-06	1.37e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Disease—FGF2—coronary artery disease	1.65e-06	1.36e-05	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism—GSTM1—coronary artery disease	1.65e-06	1.36e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—LPL—coronary artery disease	1.64e-06	1.36e-05	CbGpPWpGaD
Sulfasalazine—ABCG2—Metabolism—GPX1—coronary artery disease	1.64e-06	1.36e-05	CbGpPWpGaD
Sulfasalazine—SLCO1B1—Metabolism—MTHFR—coronary artery disease	1.63e-06	1.36e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—ABCA1—coronary artery disease	1.63e-06	1.35e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—HTR2A—coronary artery disease	1.63e-06	1.35e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Adaptive Immune System—PIK3CA—coronary artery disease	1.63e-06	1.35e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—C3—coronary artery disease	1.63e-06	1.35e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—MEF2C—coronary artery disease	1.63e-06	1.35e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—RPS6KB1—coronary artery disease	1.63e-06	1.35e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Disease—NOS3—coronary artery disease	1.62e-06	1.35e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—FGF2—coronary artery disease	1.62e-06	1.34e-05	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism—LPL—coronary artery disease	1.61e-06	1.34e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—APOB—coronary artery disease	1.6e-06	1.33e-05	CbGpPWpGaD
Sulfasalazine—ABCG2—Metabolism—CD36—coronary artery disease	1.6e-06	1.32e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—ITGB3—coronary artery disease	1.58e-06	1.31e-05	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—PLCB1—coronary artery disease	1.58e-06	1.31e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—GOT1—coronary artery disease	1.58e-06	1.31e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—GGT1—coronary artery disease	1.58e-06	1.31e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Disease—JAK2—coronary artery disease	1.58e-06	1.31e-05	CbGpPWpGaD
Sulfasalazine—ABCG2—Metabolism—PPP2CA—coronary artery disease	1.58e-06	1.31e-05	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism—GPX1—coronary artery disease	1.58e-06	1.31e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—HIF1A—coronary artery disease	1.55e-06	1.29e-05	CbGpPWpGaD
Sulfasalazine—SLCO1B1—Metabolism—AGT—coronary artery disease	1.55e-06	1.29e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—JAK2—coronary artery disease	1.55e-06	1.28e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—AGT—coronary artery disease	1.55e-06	1.28e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—FGF1—coronary artery disease	1.54e-06	1.28e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Innate Immune System—PIK3CA—coronary artery disease	1.54e-06	1.28e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—PPP2CA—coronary artery disease	1.54e-06	1.28e-05	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—ABCA1—coronary artery disease	1.53e-06	1.27e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—BCL2—coronary artery disease	1.53e-06	1.27e-05	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism—CD36—coronary artery disease	1.53e-06	1.27e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—LPL—coronary artery disease	1.53e-06	1.27e-05	CbGpPWpGaD
Sulfasalazine—SLCO1B1—Metabolism—APOE—coronary artery disease	1.52e-06	1.26e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—LEP—coronary artery disease	1.52e-06	1.26e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—APOE—coronary artery disease	1.52e-06	1.26e-05	CbGpPWpGaD
Sulfasalazine—PLA2G1B—Metabolism—AKT1—coronary artery disease	1.52e-06	1.26e-05	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism—PPP2CA—coronary artery disease	1.52e-06	1.26e-05	CbGpPWpGaD
Sulfasalazine—PPARG—Metabolism—ALB—coronary artery disease	1.51e-06	1.25e-05	CbGpPWpGaD
Sulfasalazine—ABCG2—Metabolism—MTHFR—coronary artery disease	1.51e-06	1.25e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—PRKCD—coronary artery disease	1.51e-06	1.25e-05	CbGpPWpGaD
Sulfasalazine—SLCO1B1—Metabolism—APOA1—coronary artery disease	1.5e-06	1.25e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Innate Immune System—IL6—coronary artery disease	1.5e-06	1.25e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—APOA1—coronary artery disease	1.5e-06	1.24e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—IL1B—coronary artery disease	1.5e-06	1.24e-05	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—GGT1—coronary artery disease	1.49e-06	1.23e-05	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—GOT1—coronary artery disease	1.49e-06	1.23e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—KDR—coronary artery disease	1.49e-06	1.23e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Disease—PTGS2—coronary artery disease	1.48e-06	1.23e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—HTR2A—coronary artery disease	1.48e-06	1.23e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Adaptive Immune System—PIK3CA—coronary artery disease	1.48e-06	1.23e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—C3—coronary artery disease	1.48e-06	1.23e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—MAPK14—coronary artery disease	1.48e-06	1.22e-05	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism—MTHFR—coronary artery disease	1.45e-06	1.21e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—ESR1—coronary artery disease	1.45e-06	1.2e-05	CbGpPWpGaD
Sulfasalazine—PPARG—Metabolism—NOS3—coronary artery disease	1.45e-06	1.2e-05	CbGpPWpGaD
Sulfasalazine—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	1.44e-06	1.19e-05	CbGpPWpGaD
Sulfasalazine—ABCG2—Metabolism—AGT—coronary artery disease	1.44e-06	1.19e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—PPP2CA—coronary artery disease	1.44e-06	1.19e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—FN1—coronary artery disease	1.43e-06	1.19e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—F2—coronary artery disease	1.43e-06	1.19e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—IL6ST—coronary artery disease	1.42e-06	1.18e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—GSTP1—coronary artery disease	1.42e-06	1.18e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—NFKBIA—coronary artery disease	1.41e-06	1.17e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—PRKCD—coronary artery disease	1.41e-06	1.17e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—HIF1A—coronary artery disease	1.41e-06	1.17e-05	CbGpPWpGaD
Sulfasalazine—ABCG2—Metabolism—APOE—coronary artery disease	1.41e-06	1.17e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—PPARGC1A—coronary artery disease	1.41e-06	1.17e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—AGT—coronary artery disease	1.4e-06	1.16e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—HMOX1—coronary artery disease	1.4e-06	1.16e-05	CbGpPWpGaD
Sulfasalazine—ABCG2—Metabolism—APOA1—coronary artery disease	1.39e-06	1.15e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Innate Immune System—AKT1—coronary artery disease	1.39e-06	1.15e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—CAT—coronary artery disease	1.38e-06	1.15e-05	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism—AGT—coronary artery disease	1.38e-06	1.15e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—MTHFR—coronary artery disease	1.38e-06	1.14e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—LEP—coronary artery disease	1.38e-06	1.14e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—APOE—coronary artery disease	1.38e-06	1.14e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—KIT—coronary artery disease	1.37e-06	1.14e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Innate Immune System—IL6—coronary artery disease	1.36e-06	1.13e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—APOA1—coronary artery disease	1.36e-06	1.13e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—IL1B—coronary artery disease	1.36e-06	1.12e-05	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism—APOE—coronary artery disease	1.35e-06	1.12e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—KDR—coronary artery disease	1.35e-06	1.12e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—APOB—coronary artery disease	1.34e-06	1.11e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—MAPK14—coronary artery disease	1.34e-06	1.11e-05	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism—APOA1—coronary artery disease	1.34e-06	1.11e-05	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—GSTP1—coronary artery disease	1.34e-06	1.11e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Adaptive Immune System—AKT1—coronary artery disease	1.33e-06	1.1e-05	CbGpPWpGaD
Sulfasalazine—SLCO1B1—Metabolism—PPARG—coronary artery disease	1.33e-06	1.1e-05	CbGpPWpGaD
Sulfasalazine—PPARG—Metabolism—PTGS2—coronary artery disease	1.32e-06	1.1e-05	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—PPARGC1A—coronary artery disease	1.32e-06	1.1e-05	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—HMOX1—coronary artery disease	1.32e-06	1.09e-05	CbGpPWpGaD
Sulfasalazine—ALOX5—Metabolism—PIK3CA—coronary artery disease	1.32e-06	1.09e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—HIF1A—coronary artery disease	1.31e-06	1.09e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—GSK3B—coronary artery disease	1.31e-06	1.09e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—ESR1—coronary artery disease	1.31e-06	1.09e-05	CbGpPWpGaD
Sulfasalazine—SLCO1B1—Metabolism—POMC—coronary artery disease	1.31e-06	1.08e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—GSTM1—coronary artery disease	1.31e-06	1.08e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—POMC—coronary artery disease	1.3e-06	1.08e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—CREB1—coronary artery disease	1.3e-06	1.08e-05	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—CAT—coronary artery disease	1.3e-06	1.08e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—FN1—coronary artery disease	1.3e-06	1.08e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—F2—coronary artery disease	1.3e-06	1.08e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—IL6ST—coronary artery disease	1.29e-06	1.07e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—APOE—coronary artery disease	1.28e-06	1.06e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—LPL—coronary artery disease	1.28e-06	1.06e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—NFKBIA—coronary artery disease	1.28e-06	1.06e-05	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	1.28e-06	1.06e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—CCL2—coronary artery disease	1.27e-06	1.06e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—IL6R—coronary artery disease	1.27e-06	1.05e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—APOA1—coronary artery disease	1.27e-06	1.05e-05	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—APOB—coronary artery disease	1.26e-06	1.05e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Innate Immune System—AKT1—coronary artery disease	1.26e-06	1.04e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—IGF1—coronary artery disease	1.25e-06	1.04e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—GPX1—coronary artery disease	1.25e-06	1.04e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—KIT—coronary artery disease	1.24e-06	1.03e-05	CbGpPWpGaD
Sulfasalazine—ABCG2—Metabolism—PPARG—coronary artery disease	1.23e-06	1.02e-05	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—GSTM1—coronary artery disease	1.23e-06	1.02e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—CD36—coronary artery disease	1.22e-06	1.01e-05	CbGpPWpGaD
Sulfasalazine—ABCG2—Metabolism—POMC—coronary artery disease	1.21e-06	1e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Adaptive Immune System—AKT1—coronary artery disease	1.21e-06	1e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—IL6ST—coronary artery disease	1.21e-06	9.99e-06	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—LPL—coronary artery disease	1.2e-06	9.99e-06	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—PPP2CA—coronary artery disease	1.2e-06	9.97e-06	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—NOS2—coronary artery disease	1.2e-06	9.91e-06	CbGpPWpGaD
Sulfasalazine—SLCO1B1—Metabolism—ALB—coronary artery disease	1.19e-06	9.88e-06	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—GSK3B—coronary artery disease	1.19e-06	9.88e-06	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—SERPINE1—coronary artery disease	1.19e-06	9.87e-06	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—POMC—coronary artery disease	1.18e-06	9.8e-06	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—CREB1—coronary artery disease	1.18e-06	9.8e-06	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism—PPARG—coronary artery disease	1.18e-06	9.78e-06	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—GPX1—coronary artery disease	1.17e-06	9.74e-06	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism—POMC—coronary artery disease	1.16e-06	9.64e-06	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—KIT—coronary artery disease	1.16e-06	9.6e-06	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—CCL2—coronary artery disease	1.16e-06	9.59e-06	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—MTHFR—coronary artery disease	1.15e-06	9.57e-06	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—IL6R—coronary artery disease	1.15e-06	9.56e-06	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—FGF2—coronary artery disease	1.15e-06	9.55e-06	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—CD36—coronary artery disease	1.14e-06	9.49e-06	CbGpPWpGaD
Sulfasalazine—SLCO1B1—Metabolism—NOS3—coronary artery disease	1.14e-06	9.45e-06	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—MAPK1—coronary artery disease	1.14e-06	9.45e-06	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—IGF1—coronary artery disease	1.14e-06	9.42e-06	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—NOS3—coronary artery disease	1.14e-06	9.42e-06	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—PPP2CA—coronary artery disease	1.13e-06	9.37e-06	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—GSK3B—coronary artery disease	1.11e-06	9.21e-06	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—JAK2—coronary artery disease	1.1e-06	9.16e-06	CbGpPWpGaD
Sulfasalazine—ABCG2—Metabolism—ALB—coronary artery disease	1.1e-06	9.15e-06	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—CREB1—coronary artery disease	1.1e-06	9.14e-06	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—AGT—coronary artery disease	1.1e-06	9.09e-06	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—MTHFR—coronary artery disease	1.08e-06	8.99e-06	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—SERPINE1—coronary artery disease	1.08e-06	8.95e-06	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—IL6R—coronary artery disease	1.08e-06	8.92e-06	CbGpPWpGaD
Sulfasalazine—ALOX5—Metabolism—AKT1—coronary artery disease	1.08e-06	8.91e-06	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—APOE—coronary artery disease	1.07e-06	8.91e-06	CbGpPWpGaD
Sulfasalazine—CHUK—Disease—TGFB1—coronary artery disease	1.07e-06	8.9e-06	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—APOA1—coronary artery disease	1.06e-06	8.81e-06	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism—ALB—coronary artery disease	1.06e-06	8.79e-06	CbGpPWpGaD
Sulfasalazine—ABCG2—Metabolism—NOS3—coronary artery disease	1.06e-06	8.75e-06	CbGpPWpGaD
Sulfasalazine—CHUK—Disease—MAPK1—coronary artery disease	1.05e-06	8.73e-06	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—FGF2—coronary artery disease	1.04e-06	8.66e-06	CbGpPWpGaD
Sulfasalazine—SLCO1B1—Metabolism—PTGS2—coronary artery disease	1.04e-06	8.64e-06	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—MAPK1—coronary artery disease	1.03e-06	8.57e-06	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—NOS3—coronary artery disease	1.03e-06	8.54e-06	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—AGT—coronary artery disease	1.03e-06	8.54e-06	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	1.02e-06	8.43e-06	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism—NOS3—coronary artery disease	1.01e-06	8.41e-06	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—APOE—coronary artery disease	1.01e-06	8.37e-06	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—CXCL8—coronary artery disease	1.01e-06	8.36e-06	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—SERPINE1—coronary artery disease	1.01e-06	8.35e-06	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—JAK2—coronary artery disease	1e-06	8.3e-06	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—APOA1—coronary artery disease	9.98e-07	8.27e-06	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—PIK3CA—coronary artery disease	9.89e-07	8.2e-06	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—FGF2—coronary artery disease	9.75e-07	8.08e-06	CbGpPWpGaD
Sulfasalazine—ABCG2—Metabolism—PTGS2—coronary artery disease	9.65e-07	8e-06	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—CASP3—coronary artery disease	9.65e-07	8e-06	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—NOS3—coronary artery disease	9.61e-07	7.97e-06	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—CCND1—coronary artery disease	9.39e-07	7.79e-06	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—PPARG—coronary artery disease	9.36e-07	7.76e-06	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—JAK2—coronary artery disease	9.34e-07	7.75e-06	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism—PTGS2—coronary artery disease	9.27e-07	7.69e-06	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—POMC—coronary artery disease	9.23e-07	7.65e-06	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—CXCL8—coronary artery disease	9.14e-07	7.58e-06	CbGpPWpGaD
Sulfasalazine—CHUK—Disease—PIK3CA—coronary artery disease	9.13e-07	7.57e-06	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—MMP9—coronary artery disease	9.12e-07	7.56e-06	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—PIK3CA—coronary artery disease	8.97e-07	7.44e-06	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—PPARG—coronary artery disease	8.79e-07	7.29e-06	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—IL6—coronary artery disease	8.76e-07	7.26e-06	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—CASP3—coronary artery disease	8.75e-07	7.25e-06	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—POMC—coronary artery disease	8.67e-07	7.19e-06	CbGpPWpGaD
Sulfasalazine—PPARG—Gene Expression—AKT1—coronary artery disease	8.56e-07	7.1e-06	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—CCND1—coronary artery disease	8.52e-07	7.06e-06	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—ALB—coronary artery disease	8.42e-07	6.98e-06	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—MMP9—coronary artery disease	8.27e-07	6.85e-06	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—VEGFA—coronary artery disease	8.19e-07	6.79e-06	CbGpPWpGaD
Sulfasalazine—PPARG—Metabolism—PIK3CA—coronary artery disease	8.15e-07	6.75e-06	CbGpPWpGaD
Sulfasalazine—CHUK—Disease—IL6—coronary artery disease	8.09e-07	6.7e-06	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—AKT1—coronary artery disease	8.08e-07	6.7e-06	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—NOS3—coronary artery disease	8.05e-07	6.68e-06	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—IL6—coronary artery disease	7.94e-07	6.58e-06	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—ALB—coronary artery disease	7.91e-07	6.56e-06	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—NOS3—coronary artery disease	7.56e-07	6.27e-06	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—TGFB1—coronary artery disease	7.51e-07	6.23e-06	CbGpPWpGaD
Sulfasalazine—CHUK—Disease—AKT1—coronary artery disease	7.46e-07	6.19e-06	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—VEGFA—coronary artery disease	7.42e-07	6.16e-06	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—MAPK1—coronary artery disease	7.37e-07	6.11e-06	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—AKT1—coronary artery disease	7.33e-07	6.07e-06	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—PTGS2—coronary artery disease	6.92e-07	5.74e-06	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—TGFB1—coronary artery disease	6.81e-07	5.65e-06	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—MAPK1—coronary artery disease	6.68e-07	5.54e-06	CbGpPWpGaD
Sulfasalazine—PPARG—Metabolism—AKT1—coronary artery disease	6.65e-07	5.52e-06	CbGpPWpGaD
Sulfasalazine—SLCO1B1—Metabolism—PIK3CA—coronary artery disease	6.41e-07	5.32e-06	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—PIK3CA—coronary artery disease	6.39e-07	5.3e-06	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—TGFB1—coronary artery disease	6.36e-07	5.27e-06	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—MAPK1—coronary artery disease	6.23e-07	5.17e-06	CbGpPWpGaD
Sulfasalazine—ABCG2—Metabolism—PIK3CA—coronary artery disease	5.94e-07	4.92e-06	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—PIK3CA—coronary artery disease	5.8e-07	4.81e-06	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism—PIK3CA—coronary artery disease	5.71e-07	4.73e-06	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—IL6—coronary artery disease	5.66e-07	4.7e-06	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—PIK3CA—coronary artery disease	5.41e-07	4.49e-06	CbGpPWpGaD
Sulfasalazine—SLCO1B1—Metabolism—AKT1—coronary artery disease	5.24e-07	4.34e-06	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—AKT1—coronary artery disease	5.22e-07	4.33e-06	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—IL6—coronary artery disease	5.13e-07	4.26e-06	CbGpPWpGaD
Sulfasalazine—ABCG2—Metabolism—AKT1—coronary artery disease	4.85e-07	4.02e-06	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—IL6—coronary artery disease	4.79e-07	3.97e-06	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—AKT1—coronary artery disease	4.74e-07	3.93e-06	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism—AKT1—coronary artery disease	4.66e-07	3.87e-06	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—PIK3CA—coronary artery disease	4.53e-07	3.76e-06	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—AKT1—coronary artery disease	4.42e-07	3.66e-06	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—PIK3CA—coronary artery disease	4.26e-07	3.53e-06	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—AKT1—coronary artery disease	3.7e-07	3.07e-06	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—AKT1—coronary artery disease	3.48e-07	2.88e-06	CbGpPWpGaD
